There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:DISEASE
Jump to navigation
Jump to search
(previous page) (next page)
Pages in category "DISEASE"
The following 200 pages are in this category, out of 617 total.
(previous page) (next page)A
- BRST5:Acinic cell carcinoma
- GTS5:Activated Phosphatidylinositol-3-OH kinase δ Syndrome - APDS (PIK3CD)
- HAEM5:Acute basophilic leukaemia
- HAEM4:Acute Basophilic Leukemia
- HAEM5:Acute erythroid leukaemia
- HAEM5:Acute leukaemia of ambiguous lineage with other defined genetic alterations
- HAEM5:Acute leukaemia of ambiguous lineage, NOS
- HAEM5:Acute megakaryoblastic leukaemia
- HAEM4:Acute Megakaryoblastic Leukemia (AMKL)
- HAEM4:Acute Monoblastic and Monocytic Leukemia
- HAEM5:Acute monocytic leukaemia
- HAEM5:Acute myeloid leukaemia with BCR::ABL1 fusion
- HAEM5:Acute myeloid leukaemia with CBFB::MYH11 fusion
- HAEM5:Acute myeloid leukaemia with CEBPA mutation
- HAEM5:Acute myeloid leukaemia with DEK::NUP214 fusion
- HAEM4:Acute Myeloid Leukaemia with Germline CEBPA Mutation
- HAEM5:Acute myeloid leukaemia with KMT2A rearrangement
- HAEM5:Acute myeloid leukaemia with maturation
- HAEM5:Acute myeloid leukaemia with MECOM rearrangement
- HAEM5:Acute myeloid leukaemia with minimal differentiation
- HAEM5:Acute myeloid leukaemia with NPM1 mutation
- HAEM5:Acute myeloid leukaemia with NUP98 rearrangement
- HAEM5:Acute myeloid leukaemia with other defined genetic alterations
- HAEM5:Acute myeloid leukaemia with RBM15::MRTFA fusion
- HAEM5:Acute myeloid leukaemia with RUNX1::RUNX1T1 fusion
- HAEM5:Acute myeloid leukaemia without maturation
- HAEM5:Acute myeloid leukaemia, myelodysplasia-related
- HAEM4:Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1
- HAEM4:Acute Myeloid Leukemia (AML) with BCR-ABL1
- HAEM4:Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA
- HAEM4:Acute Myeloid Leukemia (AML) with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11
- HAEM4:Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM
- HAEM4:Acute Myeloid Leukemia (AML) with Maturation
- HAEM4:Acute Myeloid Leukemia (AML) with Minimal Differentiation
- HAEM4:Acute Myeloid Leukemia (AML) with Mutated FLT3
- HAEM4:Acute Myeloid Leukemia (AML) with Mutated NPM1
- HAEM4:Acute Myeloid Leukemia (AML) with Mutated RUNX1
- HAEM4:Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes
- HAEM4:Acute Myeloid Leukemia (AML) with NUP214-ABL1
- HAEM4:Acute Myeloid Leukemia (AML) with t(4;12)(q12;p13); CHIC2-ETV6
- HAEM4:Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214
- HAEM4:Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1
- HAEM4:Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3
- HAEM4:Acute Myeloid Leukemia (AML) without Maturation
- HAEM5:Acute myelomonocytic leukaemia
- HAEM4:Acute Myelomonocytic Leukemia
- HAEM4:Acute Panmyelosis with Myelofibrosis
- HAEM5:Acute promyelocytic leukaemia with PML::RARA fusion
- HAEM4:Acute Promyelocytic Leukemia (APL) with PML-RARA
- HAEM5:Acute undifferentiated leukaemia
- HAEM4:Acute Undifferentiated Leukemia
- CNS5:Adamantinomatous craniopharyngioma
- BRST5:Adenoid cystic carcinoma
- BRST5:Adenomyoepithelioma
- HAEM5:Adult T-cell leukaemia/lymphoma
- HAEM4:Adult T-cell Leukemia/Lymphoma
- HAEM5:Aggressive NK-cell leukaemia
- HAEM4:Aggressive NK-cell Leukemia
- HAEM5:ALK-negative anaplastic large cell lymphoma
- HAEM5:ALK-positive anaplastic large cell lymphoma
- HAEM5:ALK-positive histiocytosis
- HAEM4:ALK-Positive Large B-cell Lymphoma
- HAEM5:ALK-positive large B-cell lymphoma
- HAEM5:Alpha heavy chain disease
- CNS5:Anaplastic large cell lymphoma (ALK+/ALK−)
- HAEM4:Anaplastic Large Cell Lymphoma, ALK-Negative
- HAEM4:Anaplastic Large Cell Lymphoma, ALK-Positive
- CNS5:Angiocentric glioma
- HAEM4:Angioimmunoblastic T-cell Lymphoma
- BRST5:Angiolipoma
- BRST5:Angiomatosis
- BRST5:Apocrine adenosis and adenoma
- CNS5:Astroblastoma, MN1-altered
- CNS5:Astrocytoma, IDH-mutant
- GTS5:Ataxia-telangiectasia syndrome (ATM)
- CNS5:Atypical choroid plexus papilloma
- HAEM4:Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative
- BRST5:Atypical ductal hyperplasia
- BRST5:Atypical lobular hyperplasia
- CNS5:Atypical teratoid/rhabdoid tumour
- BRST5:Atypical vascular lesions
- HAEM5:Autoimmune lymphoproliferative syndrome
- GTS5:Autoimmune lymphoproliferative syndrome (FAS)
- GTS5:AXIN2-associated polyposis (AXIN2)
B
- HAEM5:B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion
- HAEM5:B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion
- HAEM5:B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement
- HAEM5:B lymphoblastic leukaemia/lymphoma with TCF3::HLF fusion
- HAEM5:B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion
- HAEM5:B-lymphoblastic leukaemia/lymphoma
- HAEM5:B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion
- HAEM5:B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features
- HAEM5:B-lymphoblastic leukaemia/lymphoma with ETV6::RUNX1-like features
- HAEM5:B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy
- HAEM5:B-lymphoblastic leukaemia/lymphoma with hypodiploidy
- HAEM5:B-lymphoblastic leukaemia/lymphoma with iAMP21
- HAEM5:B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations
- HAEM5:B-lymphoblastic leukaemia/lymphoma, NOS
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma with iAMP21
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified
- GTS5:BAP1-related tumour predisposition syndrome (BAP1)
- GTS5:Beckwith-Wiedemann spectrum (IGF2; CDKN1C)
- GTS5:Birt-Hogg-Dube syndrome (FLCN)
- HAEM4:Blastic Plasmacytoid Dendritic Cell Neoplasm
- HAEM5:Blastic plasmacytoid dendritic cell neoplasm
- HAEM5:Bloom syndrome
- GTS5:Bloom syndrome (BLM)
- GTS5:BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)
- HAEM4:Breast Implant-Associated Anaplastic Large Cell Lymphoma
- HAEM5:Breast implant-associated anaplastic large cell lymphoma
- BRST5:Breast implant-associated anaplastic large cell lymphoma
- GTS5:Brooke-Spiegler syndrome (CYLD)
- HAEM4:Burkitt Lymphoma
- HAEM5:Burkitt lymphoma
- BRST5:Burkitt lymphoma
- HAEM4:Burkitt-Like Lymphoma with 11q Aberration
C
- BRST5:Carcinoma in situ
- BRST5:Carcinoma with apocrine differentiation
- GTS5:Carney complex (PRKAR1A, PDE8B, PDE11A)
- CNS5:Cauda equina neuroendocrine tumour (previously paraganglioma)
- GTS5:CDK4-related melanoma predisposition syndrome (CDK4)
- GTS5:CDKN2A-related tumour predisposition syndrome (CDKN2A)
- CNS5:Central neurocytoma
- CNS5:Cerebellar liponeurocytoma
- GTS5:CHEK2-related hereditary (breast) cancer predisposition syndrome (CHEK2)
- HAEM5:Childhood myelodysplastic neoplasm with increased blasts
- HAEM5:Childhood myelodysplastic neoplasm with low blasts
- CNS5:Chondrosarcoma
- CNS5:Chordoid glioma
- CNS5:Chordoma
- CNS5:Choroid plexus carcinoma
- CNS5:Choroid plexus papilloma
- HAEM5:Chronic eosinophilic leukaemia
- HAEM4:Chronic Eosinophilic Leukemia, Not Otherwise Specified
- HAEM5:Chronic lymphocytic leukaemia/small lymphocytic lymphoma
- HAEM4:Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- HAEM4:Chronic Lymphoproliferative Disorder of NK Cells
- HAEM5:Chronic myeloid leukaemia
- HAEM4:Chronic Myeloid Leukemia (CML), BCR-ABL1 Positive
- HAEM5:Chronic myelomonocytic leukaemia
- HAEM4:Chronic Myelomonocytic Leukemia (CMML)
- HAEM5:Chronic neutrophilic leukaemia
- HAEM4:Chronic Neutrophilic Leukemia (CNL)
- CNS5:CIC-rearranged sarcoma
- CNS5:Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma
- HAEM5:Classic Hodgkin lymphoma
- GTS5:Clear cell meningioma predisposition syndrome (SMARCE1)
- HAEM5:Clonal cytopenias of undetermined significance
- HAEM5:Clonal haematopoiesis
- CNS5:CNS embryonal tumour NEC/NOS
- CNS5:CNS neuroblastoma, FOXR2-activated
- CNS5:CNS tumour with BCOR internal tandem duplication
- HAEM5:Cold agglutinin disease
- BRST5:Columnar cell lesions, including flat epithelial atypia
- GTS5:Constitutional mismatch repair deficiency (CMMRD) syndrome (MLH1, PMS2, MSH2, MSH6)
- GTS5:Costello syndrome (HRAS)
- BRST5:Cribriform carcinoma
- CNS5:Cribriform neuroepithelial tumour
- HAEM4:Cutaneous Mastocytosis
- HAEM5:Cutaneous mastocytosis
D
- GTS5:DDX41-related haematologic tumour predisposition syndrome (DDX41)
- BRST5:Desmoid fibromatosis
- CNS5:Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma
- CNS5:Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant
- GTS5:DICER1-related tumour predisposition syndrome (DICER1)
- CNS5:Diffuse astrocytoma, MYB- or MYBL1-altered
- CNS5:Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters
- CNS5:Diffuse hemispheric glioma, H3 G34-mutant
- BRST5:Diffuse large B-cell lymphoma
- HAEM5:Diffuse large B-cell lymphoma / high grade B-cell lymphoma with MYC and BCL2 rearrangements
- HAEM5:Diffuse large B-cell lymphoma associated with chronic inflammation
- HAEM5:Diffuse large B-cell lymphoma, NOS
- HAEM4:Diffuse Large B-cell Lymphoma, Not Otherwise Specified
- CNS5:Diffuse leptomeningeal glioneuronal tumour
- CNS5:Diffuse low-grade glioma, MAPK pathway-altered
- CNS5:Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis
- CNS5:Diffuse midline glioma, H3 K27-altered
- CNS5:Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype
- GTS5:Down syndrome
- BRST5:Ductal adenoma
- BRST5:Ductal carcinoma in situ
- HAEM5:Duodenal-type follicular lymphoma
- CNS5:Dysembryoplastic neuroepithelial tumour
- GTS5:Dyskeratosis congenita (DKC1, TERT, TERC, TINF2, Other IBMFS genes)
- CNS5:Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)